<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02899624</url>
  </required_header>
  <id_info>
    <org_study_id>2013-09</org_study_id>
    <nct_id>NCT02899624</nct_id>
  </id_info>
  <brief_title>Whole Exome Sequencing in Bicuspid Aortic Valve Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bicuspid aortic valve (BAV), congenital anomaly present in 2% of the population, is defined
      by the presence of two sigmoid valves instead of three. It is conventionally associated with
      histological abnormalities of the wall of the ascending aorta, risk factors of aortic
      dystrophy observed in 50% of cases, and dissection. Long considered an accident of
      development, the discovery of mutations in the NOTCH1 gene in 2 families alternating BAV and
      aortic dystrophy suggests the existence of a genetic predisposition and a common genetic
      origin for these two pathologies.

      Data on the genetic basis of the BAV are still limited, but the existence of a large
      phenotypic diversity suggests the involvement of other genes. The establishment of large
      collections of DNA will allow great advances in this field.

      The purpose of this project is to confirm the existence of a genetic determinism at the
      origin of the BAV with or without dystrophy of non syndromic ascending aorta, identifying
      genetic defects associated with the presence of a BAV in a series of candidate genes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of genetic abnormalities</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">427</enrollment>
  <condition>Bicuspid Aortic Valve</condition>
  <arm_group>
    <arm_group_label>Bicuspid aortic valve (BAV)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patient with bicuspid aortic valve</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy subjects related patients with BAV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>healthy control, related to patient with bicuspid aortic valve, at the 1st, 2nd or 3rd degree</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tricuspid aortic valve (TAV)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patient with aortic stenosis on tricuspid valve</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Extra blood draw samples</intervention_name>
    <arm_group_label>Bicuspid aortic valve (BAV)</arm_group_label>
    <arm_group_label>healthy subjects related patients with BAV</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>additional tissue samples</intervention_name>
    <arm_group_label>Bicuspid aortic valve (BAV)</arm_group_label>
    <arm_group_label>Tricuspid aortic valve (TAV)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  bicuspid aortic valve, confirmed by transthoracic or transesophageal echocardiography

          -  With or without an aneurysm of the ascending thoracic aorta nonsyndromic

        Exclusion Criteria:

          -  aortic syndromic pathology

          -  antecedent of acute articular rhumatism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Urielle Desalbres</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean François Avierinos</last_name>
    <email>jean-francois.avierinos@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assistance Publique Hôpitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-François Avierinos</last_name>
      <email>jean-francois.avierinos@ap-hm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2016</study_first_submitted>
  <study_first_submitted_qc>September 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2016</study_first_posted>
  <last_update_submitted>September 9, 2016</last_update_submitted>
  <last_update_submitted_qc>September 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Valve Diseases</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

